BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15378852)

  • 21. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diffusion of latex nanospheres and the effective (microscopic) viscosity of HPMC gels.
    Ruenraroengsak P; Florence AT
    Int J Pharm; 2005 Jul; 298(2):361-6. PubMed ID: 15939561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of ophthalmic suspensions using surface tension.
    Yasueda S; Inada K; Matsuhisa K; Terayama H; Ohtori A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):377-82. PubMed ID: 15018999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
    Siepmann J; Kranz H; Bodmeier R; Peppas NA
    Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extended release properties of HPMC matrices in the presence of dietary sugars.
    Williams HD; Ward R; Hardy IJ; Melia CD
    J Control Release; 2009 Sep; 138(3):251-9. PubMed ID: 19464331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):316-22. PubMed ID: 9050799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet.
    Chirico S; Dalmoro A; Lamberti G; Russo G; Titomanlio G
    J Control Release; 2007 Sep; 122(2):181-8. PubMed ID: 17706830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
    Gonzalez YM; Ghaly ES
    Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the diffusion coefficient of water vapor through glassy HPMC films at different environmental conditions using the free volume additivity approach.
    Laksmana FL; Hartman Kok PJ; Vromans H; Van der Voort Maarschalk K
    Eur J Pharm Sci; 2009 Jul; 37(5):545-54. PubMed ID: 19409985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
    Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting drug release from HPMC/lactose tablets.
    Siepmann J; Karrout Y; Gehrke M; Penz FK; Siepmann F
    Int J Pharm; 2013 Jan; 441(1-2):826-34. PubMed ID: 23262427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.